These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 18501095

  • 1. Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment.
    Bayman NA, Blackhall F, Jain P, Lee L, Thatcher N, Faivre-Finn C.
    Clin Lung Cancer; 2008 Mar; 9(2):92-101. PubMed ID: 18501095
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.
    Langer CJ, Curran WJ, Keller SM, Catalano RB, Litwin S, Blankstein KB, Haas N, Campli SN, Comis RL.
    Cancer J Sci Am; 1996 Mar; 2(2):99-105. PubMed ID: 9166507
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Recent issues in the treatment of advanced non-small-cell lung cancer].
    Negoro S.
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1671-9. PubMed ID: 9757191
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined modality therapy for stage III non-small cell lung cancer.
    Stinchcombe TE, Fried D, Morris DE, Socinski MA.
    Oncologist; 2006 Sep; 11(7):809-23. PubMed ID: 16880240
    [Abstract] [Full Text] [Related]

  • 14. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
    Belani CP.
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combined modality therapy for non-small cell lung carcinoma.
    Machtay M, Glatstein E.
    Cancer J; 2002 Feb; 8 Suppl 1():S55-67. PubMed ID: 12075703
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.
    Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF, Green MR.
    N Engl J Med; 1990 Oct 04; 323(14):940-5. PubMed ID: 2169587
    [Abstract] [Full Text] [Related]

  • 18. Analysis of a novel protocol of combined induction chemotherapy and concurrent chemoradiation in unresected non-small-cell lung cancer: a ten-year experience with vinblastine, Cisplatin, and radiation therapy.
    Waters E, Dingle B, Rodrigues G, Vincent M, Ash R, Dar R, Inculet R, Kocha W, Malthaner R, Sanatani M, Stitt L, Yaremko B, Younus J, Yu E.
    Clin Lung Cancer; 2010 Jul 01; 11(4):243-50. PubMed ID: 20630826
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.